| Jul 12 |
Entrada Therapeutics (TRDA) Moves 10.4% Higher: Will This Strength Last?
|
| Jul 10 |
Strength Seen in Travere (TVTX): Can Its 8.8% Jump Turn into More Strength?
|
| Jul 9 |
Best Momentum Stocks to Buy for July 9th
|
| Jun 27 |
With 40% ownership, Entrada Therapeutics, Inc. (NASDAQ:TRDA) has piqued the interest of institutional investors
|
| Jun 24 |
Entrada Therapeutics announces $100M registered direct offering
|
| Jun 24 |
Entrada Therapeutics Announces $100 Million Registered Direct Offering
|
| Jun 24 |
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
|
| Jun 16 |
Entrada Therapeutics: A Complicated Tale
|
| Jun 3 |
Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
|
| May 21 |
Wall Street Analysts Think Entrada Therapeutics (TRDA) Could Surge 37.08%: Read This Before Placing a Bet
|
